Diffusing capacity for carbon monoxide (DLCO) change and outcome in advanced non-small cell lung cancer (aNSCLC) treated with immune checkpoint inhibitors (ICIs).
Por:
Montes A, Sanchez A, Rondán M, Cases S, Soler J, Tena I, Navarro B, Timacheva D, Modesto M, Lorente D
Publicada:
1 jun 2025
Resumen:
|